uric acid has been researched along with Hypercholesterolemia in 144 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study included two age-, weight-, lipid-, and prolactin level-matched groups of premenopausal women with hypecholesterolemia and a history of hyperprolactinemia: patients treated with bromocriptine (5." | 9.20 | The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia. ( Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W, 2015) |
| "An assessment of the effects of ezetimibe and orlistat administration, alone or in combination, on LDL-C and sdLDL-C levels (primary endpoint), as well as on anthropometric variables and metabolic parameters (secondary endpoints) in overweight and obese patients [body mass index (BMI)>28 kg/m(2)] with hypercholesterolaemia [total cholesterol>200 mg/dL (5." | 9.13 | The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. ( Elisaf, MS; Filippatos, TD; Georgoula, M; Kiortsis, DN; Mikhailidis, DP; Nakou, ES; Tselepis, AD, 2008) |
| "Our aim in this study was to investigate the changes of serum high-sensitive C-reactive protein (hs-CRP) and uric acid (UA), and evaluate the synergistic effect of amlodipine and atorvastatin on blood pressure and left ventricular remodeling in hypertensive patients with primary hypercholesterolemia." | 9.13 | Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. ( Chen, YD; Ge, CJ; Hu, SJ; Ji, Y; Lu, SZ; Wu, XF, 2008) |
| "We compared two matched groups of euthyroid women with hypercholesterolemia receiving atorvastatin treatment: subjects with autoimmune (Hashimoto's) thyroiditis (group A, n = 29) and subjects without thyroid pathology (group B, n = 29)." | 8.31 | Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis. ( Kowalcze, K; Krysiak, R; Okopień, B, 2023) |
| "We studied 12 women with NC-CAH, 6 of whom because of coexisting hypercholesterolemia received atorvastatin (20-40 mg daily)." | 7.91 | The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study. ( Bednarska-Czerwińska, A; Kowalcze, K; Krysiak, R; Okopień, B, 2019) |
| "To investigate the effects on hypercholesterolemia and hypertriglyceridemia in gouty patients receiving uric acid-lowering therapy (UALT)." | 7.91 | Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients. ( Deng, JX; Jie, LG; Qu, Y; Wu, J; Yu, QH; Zhang, YP, 2019) |
| "To investigate if increased lipid peroxidation is involved in hypercholesterolemia-induced hypertension and renal injury, we examined the effects of allopurinol, a xanthine oxidase inhibitor, on these conditions." | 7.73 | Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats. ( Atarashi, K; Ishiyama, A; Minami, M; Omata, M; Takagi, M, 2005) |
| "The study included two age-, weight-, lipid-, and prolactin level-matched groups of premenopausal women with hypecholesterolemia and a history of hyperprolactinemia: patients treated with bromocriptine (5." | 5.20 | The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia. ( Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W, 2015) |
| "An assessment of the effects of ezetimibe and orlistat administration, alone or in combination, on LDL-C and sdLDL-C levels (primary endpoint), as well as on anthropometric variables and metabolic parameters (secondary endpoints) in overweight and obese patients [body mass index (BMI)>28 kg/m(2)] with hypercholesterolaemia [total cholesterol>200 mg/dL (5." | 5.13 | The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. ( Elisaf, MS; Filippatos, TD; Georgoula, M; Kiortsis, DN; Mikhailidis, DP; Nakou, ES; Tselepis, AD, 2008) |
| "Our aim in this study was to investigate the changes of serum high-sensitive C-reactive protein (hs-CRP) and uric acid (UA), and evaluate the synergistic effect of amlodipine and atorvastatin on blood pressure and left ventricular remodeling in hypertensive patients with primary hypercholesterolemia." | 5.13 | Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. ( Chen, YD; Ge, CJ; Hu, SJ; Ji, Y; Lu, SZ; Wu, XF, 2008) |
| "We compared two matched groups of euthyroid women with hypercholesterolemia receiving atorvastatin treatment: subjects with autoimmune (Hashimoto's) thyroiditis (group A, n = 29) and subjects without thyroid pathology (group B, n = 29)." | 4.31 | Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis. ( Kowalcze, K; Krysiak, R; Okopień, B, 2023) |
| "We studied 12 women with NC-CAH, 6 of whom because of coexisting hypercholesterolemia received atorvastatin (20-40 mg daily)." | 3.91 | The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study. ( Bednarska-Czerwińska, A; Kowalcze, K; Krysiak, R; Okopień, B, 2019) |
| "To investigate the effects on hypercholesterolemia and hypertriglyceridemia in gouty patients receiving uric acid-lowering therapy (UALT)." | 3.91 | Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients. ( Deng, JX; Jie, LG; Qu, Y; Wu, J; Yu, QH; Zhang, YP, 2019) |
| "To investigate if increased lipid peroxidation is involved in hypercholesterolemia-induced hypertension and renal injury, we examined the effects of allopurinol, a xanthine oxidase inhibitor, on these conditions." | 3.73 | Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats. ( Atarashi, K; Ishiyama, A; Minami, M; Omata, M; Takagi, M, 2005) |
| " The diabetic dams presented hyperglycemia, hyperlipemia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, decreased reduced glutathione (GSH), hepatic glycogen and superoxide dismutase (SOD) determinations." | 3.71 | Oxidative stress and diabetes in pregnant rats. ( Cunha Rudge, MV; Damasceno, DC; de Mattos Paranhos Calderon, I; Volpato, GT, 2002) |
| " Except for them, the gamma-GTP level was positively correlated with levels of insulin resistance, uric acid, total cholesterol, triglyceride, and body mass index." | 3.71 | Significant correlation between insulin resistance and serum gamma-glutamyl transpeptidase (gamma-GTP) activity in non-drinkers. ( Hirose, H; Moriya, S; Saito, I; Yokoyama, H, 2002) |
| " With the impression of primary hypothyroidism, the patient was started on levothyroxine supplementation at which point he developed a classic gouty arthritis of right first metatarsophalangial joint." | 3.70 | Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism. ( Bastani, B; Mooraki, A, 1998) |
| "We carried out a study of 43 male asymptomatic subjects with high levels of uric acid but showing no signs of arterial hypertension, obesity or alcohol abuse." | 3.68 | Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse. ( Añon Barbudo, J; Collantes Estevez, E; Pineda Priego, M; Sanchez Guijo, P, 1990) |
| " Data on blood pressure, obesity and serum lipids are presented here, and are discussed together with smoking and serum uric acid." | 3.65 | Coronary risk factors in New Zealand Maori and European adolescents: The Rotoua Lakes Study 2. ( Malcolm, JB; Stanhope, JM, 1975) |
| "Insulin sensitivity was assessed by hyperinsulinaemic-euglycaemic clamps and cardiovascular variables were measured." | 2.84 | Comparison of the effects of diets high in animal or plant protein on metabolic and cardiovascular markers in type 2 diabetes: A randomized clinical trial. ( Hornemann, S; Markova, M; Pfeiffer, AFH; Pivovarova, O; Rohn, S; Rudovich, N; Schneeweiss, R; Sucher, S; Thomann, R, 2017) |
| "Lercanidipine is a calcium channel blockers of high efficacy and low incidence of adverse effects in the clinical settings of general practice." | 2.71 | [Evaluation of lercanidipine in the general practice setting]. ( Aguilar, A; Angulo, E; Canelada, JA; Cidoncha, F; Díaz Olea, E; Fuentes, J; Garrido, J; Guerras, M; Hidalgo, P; Iglesias, M; Lapie, J; López Acedo, A; Peña, J; Robles, NR, 2003) |
| "Uric acid was significantly reduced only during the first period of treatment (p less than 0." | 2.64 | Clofibrate in type II hyperlipoproteinemia. ( Bang, HO; Ditzel, J, 1976) |
| "After full adjustment, we observed a positive linear dose-response relationship between SUA and hypercholesterolaemia and hypertriglyceridaemia." | 1.56 | Serum uric acid and risk of incident hypercholesterolaemia and hypertriglyceridaemia in middle-aged and older Chinese: a 4-year prospective cohort study. ( Jia, C; Li, Y; Tian, L; Zheng, H, 2020) |
| "CONCLUSIONS GPS may be an effective treatment for hyperuricemia via a decrease in xanthine oxidoreductase through the XOD/XDH system; and via an increase in urate excretion through regulating URAT1, GLUT9, and OAT1 transporters." | 1.46 | Gypenosides Inhibits Xanthine Oxidoreductase and Ameliorates Urate Excretion in Hyperuricemic Rats Induced by High Cholesterol and High Fat Food (Lipid Emulsion). ( Chen, B; Chen, S; Fang, Y; Hu, H; Li, B; Liang, K; Lv, G; Pang, M; Shan, C; Su, J; Yang, Y; Yu, J; Zhu, X, 2017) |
| "Hyperuricemia was more prevalent in men than in women (32." | 1.33 | The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. ( Dong, Y; Gao, W; Nan, H; Qian, R; Qiao, Q; Tang, B; Tuomilehto, J, 2006) |
| "The prognosis of IgA nephropathy (IgAN) is variable and about 10-20% of patients progress to end-stage renal disease (ESRD) in 10 years." | 1.31 | Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. ( Mustonen, J; Pasternack, A; Syrjänen, J, 2000) |
| "Patients with NIDDM had 11% increase of high density lipoprotein-cholesterol (HDL-C) level at the end of the first, and 18% increase at the end of the second month, while patients with primary hyperlipoproteinaemia did not change significantly." | 1.30 | Treatment possibility of hypercholesterolaemia associated with hypertriglyceridaemia. ( Balogh, Z; Boda, J; Kárpáti, L; Kovács, P; Leövey, A; Paragh, G; Szabó, J, 1997) |
| "Diabetes Mellitus was defined as fasting blood glucose over 110 mg/dl, or the initiation of diabetic therapy." | 1.30 | Health risk assessment for diabetes mellitus based on longitudinal analysis of MHTS database. ( Hinohara, S; Izuno, T; Miyakawa, M; Nakamura, K; Sugimori, H; Takahashi, E; Tanaka, C; Yoshida, K, 1998) |
| "Insulin resistance was estimated by homeostasis model assessment (HOMA(IR)), preliminarily validated against a euglycemic-hyperinsulinemic clamp in 85 subjects." | 1.30 | Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. ( Alberiche, M; Bonadonna, RC; Bonora, E; Egger, G; Kiechl, S; Muggeo, M; Oberhollenzer, F; Targher, G; Willeit, J, 1998) |
| "Analysis of 29 kindred showed hyperlipidemia in half of adult blood relatives; half of these had type III, the remainder usually had sample endogenous hyperglyceridemia (type IV)." | 1.25 | The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. ( Fredrickson, DS; Levy, RI; Morganroth, J, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 90 (62.50) | 18.7374 |
| 1990's | 13 (9.03) | 18.2507 |
| 2000's | 17 (11.81) | 29.6817 |
| 2010's | 18 (12.50) | 24.3611 |
| 2020's | 6 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Vargas-Morales, JM | 2 |
| Guevara-Cruz, M | 2 |
| Aradillas-García, C | 2 |
| G Noriega, L | 2 |
| Tovar, A | 2 |
| Alegría-Torres, JA | 2 |
| Palatini, P | 1 |
| Virdis, A | 1 |
| Masi, S | 1 |
| Mengozzi, A | 1 |
| Casiglia, E | 1 |
| Tikhonoff, V | 1 |
| Cicero, AFG | 1 |
| Ungar, A | 1 |
| Parati, G | 1 |
| Rivasi, G | 1 |
| Salvetti, M | 1 |
| Barbagallo, CM | 1 |
| Bombelli, M | 1 |
| Dell'Oro, R | 1 |
| Bruno, B | 1 |
| Lippa, L | 1 |
| D'Elia, L | 1 |
| Masulli, M | 1 |
| Verdecchia, P | 1 |
| Reboldi, G | 1 |
| Angeli, F | 1 |
| Mallamaci, F | 1 |
| Cirillo, M | 1 |
| Rattazzi, M | 1 |
| Cirillo, P | 1 |
| Gesualdo, L | 1 |
| Mazza, A | 1 |
| Giannattasio, C | 1 |
| Maloberti, A | 1 |
| Volpe, M | 1 |
| Tocci, G | 1 |
| Iaccarino, G | 1 |
| Nazzaro, P | 1 |
| Galletti, F | 1 |
| Ferri, C | 1 |
| Desideri, G | 1 |
| Viazzi, F | 1 |
| Pontremoli, R | 1 |
| Muiesan, ML | 1 |
| Grassi, G | 1 |
| Borghi, C | 1 |
| Krysiak, R | 3 |
| Kowalcze, K | 2 |
| Okopień, B | 3 |
| Teramura, S | 1 |
| Yamagishi, K | 1 |
| Umesawa, M | 1 |
| Hayama-Terada, M | 1 |
| Muraki, I | 1 |
| Maruyama, K | 1 |
| Tanaka, M | 1 |
| Kishida, R | 1 |
| Kihara, T | 1 |
| Takada, M | 1 |
| Ohira, T | 1 |
| Imano, H | 1 |
| Shimizu, Y | 1 |
| Sankai, T | 1 |
| Okada, T | 1 |
| Kitamura, A | 1 |
| Kiyama, M | 1 |
| Iso, H | 1 |
| Li, Y | 1 |
| Tian, L | 1 |
| Zheng, H | 1 |
| Jia, C | 1 |
| Li, M | 1 |
| Cui, Z | 1 |
| Meng, S | 1 |
| Li, T | 1 |
| Kang, T | 1 |
| Ye, Q | 1 |
| Cao, M | 1 |
| Bi, Y | 1 |
| Meng, H | 1 |
| Alegría-Díaz, A | 1 |
| Valdez-Ortiz, R | 1 |
| Murguía-Romero, M | 1 |
| Jiménez-Flores, R | 1 |
| Villalobos-Molina, R | 1 |
| Mummidi, S | 1 |
| Duggirala, R | 1 |
| López-Alvarenga, JC | 1 |
| Pérez-Navarro, M | 1 |
| Yuan, Y | 1 |
| Huang, F | 2 |
| Lin, F | 1 |
| Lin, M | 1 |
| Zhu, P | 1 |
| Bednarska-Czerwińska, A | 1 |
| Wu, J | 1 |
| Zhang, YP | 1 |
| Qu, Y | 1 |
| Jie, LG | 1 |
| Deng, JX | 1 |
| Yu, QH | 1 |
| Ndrepepa, G | 1 |
| Cassese, S | 1 |
| Braun, S | 1 |
| Fusaro, M | 1 |
| King, L | 1 |
| Tada, T | 1 |
| Schömig, A | 1 |
| Kastrati, A | 1 |
| Schmidt, R | 1 |
| Mendes, B | 1 |
| Silva, P | 1 |
| Mendonça, I | 1 |
| Pereira, J | 1 |
| Câmara, JS | 1 |
| Qin, Y | 1 |
| Shu, F | 1 |
| Zeng, Y | 1 |
| Meng, X | 1 |
| Wang, B | 1 |
| Diao, L | 1 |
| Wang, L | 1 |
| Wan, J | 1 |
| Zhu, J | 1 |
| Wang, J | 1 |
| Mi, M | 1 |
| Houssen, ME | 1 |
| El-Mahdy, RH | 1 |
| Shahin, DA | 1 |
| Gilowski, W | 1 |
| Szkrobka, W | 1 |
| Chen, S | 2 |
| Guo, X | 2 |
| Zhang, X | 1 |
| Yu, S | 2 |
| Yang, H | 2 |
| Jiang, M | 1 |
| Sun, G | 1 |
| Sun, Y | 2 |
| Zheng, L | 1 |
| Ai, Z | 1 |
| Xu, R | 1 |
| Liu, W | 1 |
| Zhou, Q | 1 |
| Li, B | 2 |
| Yu, X | 1 |
| Yang, Q | 1 |
| Sucher, S | 1 |
| Markova, M | 1 |
| Hornemann, S | 1 |
| Pivovarova, O | 1 |
| Rudovich, N | 1 |
| Thomann, R | 1 |
| Schneeweiss, R | 1 |
| Rohn, S | 1 |
| Pfeiffer, AFH | 1 |
| Pang, M | 1 |
| Fang, Y | 1 |
| Zhu, X | 1 |
| Shan, C | 1 |
| Su, J | 1 |
| Yu, J | 1 |
| Yang, Y | 1 |
| Chen, B | 1 |
| Liang, K | 1 |
| Hu, H | 1 |
| Lv, G | 1 |
| Nakou, ES | 1 |
| Filippatos, TD | 1 |
| Georgoula, M | 1 |
| Kiortsis, DN | 1 |
| Tselepis, AD | 1 |
| Mikhailidis, DP | 1 |
| Elisaf, MS | 1 |
| Percario, S | 1 |
| Odorizzi, VF | 1 |
| Souza, DR | 1 |
| Pinhel, MA | 1 |
| Gennari, JL | 1 |
| Gennari, MS | 1 |
| Godoy, MF | 1 |
| Lin, ZJ | 1 |
| Zhang, B | 1 |
| Liu, XQ | 1 |
| Yang, HL | 1 |
| Kuo, CF | 1 |
| Luo, SF | 1 |
| See, LC | 1 |
| Ko, YS | 1 |
| Chen, YM | 1 |
| Hwang, JS | 1 |
| Chou, IJ | 1 |
| Chang, HC | 1 |
| Chen, HW | 1 |
| Yu, KH | 1 |
| Katsuren, K | 1 |
| Nakamura, K | 2 |
| Ohta, T | 1 |
| Zinellu, A | 1 |
| Sotgia, S | 1 |
| Loriga, G | 1 |
| Deiana, L | 1 |
| Satta, AE | 1 |
| Carru, C | 1 |
| Miglio, C | 1 |
| Peluso, I | 1 |
| Raguzzini, A | 1 |
| Villaño, DV | 1 |
| Cesqui, E | 1 |
| Catasta, G | 1 |
| Toti, E | 1 |
| Serafini, M | 1 |
| Damasceno, DC | 1 |
| Volpato, GT | 1 |
| de Mattos Paranhos Calderon, I | 1 |
| Cunha Rudge, MV | 1 |
| Yokoyama, H | 1 |
| Hirose, H | 1 |
| Moriya, S | 1 |
| Saito, I | 1 |
| Robles, NR | 1 |
| Canelada, JA | 1 |
| Iglesias, M | 1 |
| Angulo, E | 1 |
| López Acedo, A | 1 |
| Díaz Olea, E | 1 |
| Cidoncha, F | 1 |
| Guerras, M | 1 |
| Fuentes, J | 1 |
| Garrido, J | 1 |
| Lapie, J | 1 |
| Peña, J | 1 |
| Aguilar, A | 1 |
| Hidalgo, P | 1 |
| KOHN, PM | 1 |
| PROZAN, GB | 1 |
| PARSONS, WB | 1 |
| WALKER, AR | 1 |
| MISTRY, SD | 1 |
| SEFTEL, HC | 1 |
| PERET RIERA, J | 1 |
| MURIACH, V | 1 |
| BALAGUER VINTRO, I | 1 |
| BARCELO, P | 1 |
| GIULIANI, A | 1 |
| SAMMARTINO, V | 1 |
| SCHOENFELD, MR | 1 |
| GOLDBERGER, E | 1 |
| BARNETT, AJ | 1 |
| CARSON, V | 1 |
| DE MEIRING, PV | 1 |
| BERKOWITZ, D | 3 |
| TRAVIA, L | 1 |
| MARINOFF, SC | 1 |
| LEMPERT, P | 1 |
| MANDEL, EE | 1 |
| Nakanishi, N | 1 |
| Nishina, K | 1 |
| Okamoto, M | 1 |
| Yoshida, H | 1 |
| Matsuo, Y | 1 |
| Suzuki, K | 1 |
| Tatara, K | 1 |
| Balasubramanian, T | 1 |
| Palmer, BF | 1 |
| Carlson, LA | 1 |
| Minami, M | 1 |
| Ishiyama, A | 1 |
| Takagi, M | 1 |
| Omata, M | 1 |
| Atarashi, K | 1 |
| Nan, H | 1 |
| Qiao, Q | 1 |
| Dong, Y | 1 |
| Gao, W | 1 |
| Tang, B | 1 |
| Qian, R | 1 |
| Tuomilehto, J | 1 |
| Ge, CJ | 1 |
| Lu, SZ | 1 |
| Chen, YD | 1 |
| Wu, XF | 1 |
| Hu, SJ | 1 |
| Ji, Y | 1 |
| Meier, MS | 1 |
| Deutscher, S | 1 |
| Kjelsberg, MO | 1 |
| Epstein, FH | 2 |
| Heyden-Stucki, S | 1 |
| Schibler-Reich, S | 1 |
| Herman, JB | 1 |
| Goldbourt, U | 1 |
| Gambina, G | 1 |
| Corso, L | 1 |
| Deotto, L | 1 |
| Tarondi, GL | 1 |
| Brighenti, M | 1 |
| Ciccarelli, C | 1 |
| Preite, G | 1 |
| Zardini, GB | 1 |
| Montanari, M | 1 |
| Sbarbaro, V | 1 |
| Grajek, S | 1 |
| Jasiński, K | 1 |
| Paradowski, S | 1 |
| Jurczykowski, T | 1 |
| Szmydt, W | 1 |
| Adamski, M | 1 |
| Cieślicka, T | 1 |
| Ziemiański, A | 1 |
| Ochotny, R | 1 |
| Droszcz, C | 1 |
| Contaldo, F | 1 |
| Di Biase, G | 1 |
| Giacco, A | 1 |
| Pacioni, D | 1 |
| Moro, CO | 1 |
| Grasso, L | 1 |
| Mancini, M | 2 |
| Fidanza, F | 1 |
| Perry, HM | 1 |
| Mamasaliev, NS | 1 |
| Tursunov, SIu | 1 |
| Nabieva, AF | 1 |
| Schneider, H | 4 |
| Pastow, A | 1 |
| Piorkowski, P | 1 |
| Kinner, B | 1 |
| Sauer, I | 1 |
| Ziegelasch, HJ | 3 |
| Steinmetz, J | 1 |
| Panek, E | 1 |
| Siest, G | 1 |
| Ladurner, G | 1 |
| Skvarc, A | 1 |
| Ott, E | 1 |
| Lechner, H | 1 |
| Barriales Alvarez, V | 1 |
| Rodríguez Blanco, VM | 1 |
| Barriales Villa, R | 1 |
| Möller Bustinza, I | 1 |
| Batalla Celorio, A | 1 |
| Castellanos Martínez, E | 1 |
| Moris de la Tassa, C | 1 |
| Mayordomo López, J | 1 |
| Drabo, PY | 1 |
| Guira, O | 1 |
| Ouandaogo, BJ | 1 |
| Kabore, J | 1 |
| Marcisz, C | 1 |
| Jonderko, G | 1 |
| Olak, Z | 1 |
| Hackenbroch, MH | 1 |
| Paragh, G | 1 |
| Balogh, Z | 1 |
| Boda, J | 1 |
| Kovács, P | 1 |
| Kárpáti, L | 1 |
| Szabó, J | 1 |
| Leövey, A | 1 |
| Mooraki, A | 1 |
| Bastani, B | 1 |
| Zhioua, R | 1 |
| Sebaï, L | 1 |
| Kriaa, L | 1 |
| el Euch, M | 1 |
| Mabrouk, S | 1 |
| Ouertani, A | 1 |
| Sugimori, H | 1 |
| Miyakawa, M | 1 |
| Yoshida, K | 1 |
| Izuno, T | 1 |
| Takahashi, E | 1 |
| Tanaka, C | 1 |
| Hinohara, S | 1 |
| Bonora, E | 1 |
| Kiechl, S | 1 |
| Willeit, J | 1 |
| Oberhollenzer, F | 1 |
| Egger, G | 1 |
| Targher, G | 1 |
| Alberiche, M | 1 |
| Bonadonna, RC | 1 |
| Muggeo, M | 1 |
| Syrjänen, J | 1 |
| Mustonen, J | 1 |
| Pasternack, A | 1 |
| Masuoka, H | 1 |
| Kamei, S | 1 |
| Wagayama, H | 1 |
| Ozaki, M | 1 |
| Kawasaki, A | 1 |
| Tanaka, T | 1 |
| Kitamura, M | 1 |
| Katoh, S | 1 |
| Shintani, U | 1 |
| Misaki, M | 1 |
| Sugawa, M | 1 |
| Ito, M | 1 |
| Nakano, T | 1 |
| Kaikkonen, J | 1 |
| Nyyssönen, K | 1 |
| Tomasi, A | 1 |
| Iannone, A | 1 |
| Tuomainen, TP | 1 |
| Porkkala-Sarataho, E | 1 |
| Salonen, JT | 1 |
| Moriel, P | 1 |
| Pereira, IR | 1 |
| Bertolami, MC | 1 |
| Abdalla, DS | 1 |
| Morganroth, J | 1 |
| Levy, RI | 1 |
| Fredrickson, DS | 1 |
| Ditzel, J | 1 |
| Bang, HO | 1 |
| Hjermann, I | 1 |
| Enger, SC | 1 |
| Helgeland, A | 1 |
| Holme, I | 1 |
| Leren, P | 1 |
| Trygg, K | 1 |
| Krause, D | 1 |
| Stang, A | 1 |
| Zezschwitz, W | 1 |
| Opherk, D | 1 |
| Scola, R | 1 |
| Morgenstern, W | 1 |
| Stockmann, G | 1 |
| Nüssel, E | 2 |
| Kübler, W | 1 |
| de Oliveira, JM | 1 |
| Höpker, WW | 1 |
| Pasternak, G | 1 |
| Zdichynec, B | 2 |
| Mensen, H | 1 |
| Beaumont, V | 1 |
| Jacotot, B | 1 |
| Beaumont, JL | 1 |
| Matzkies, F | 1 |
| Berg, G | 1 |
| Berndt, G | 1 |
| Stanhope, JM | 1 |
| Malcolm, JB | 1 |
| Chrysant, SG | 1 |
| Neller, GK | 1 |
| Dillard, B | 1 |
| Frohlich, ED | 1 |
| Lequesne, M | 1 |
| Bensasson, M | 1 |
| Kahn, MF | 1 |
| de Sèze, S | 1 |
| Hartl, O | 1 |
| Clodi, PH | 1 |
| Di Pietro, S | 1 |
| Suraci, C | 1 |
| Loenen, HM | 1 |
| Eshuis, H | 1 |
| Löwik, MR | 1 |
| Schouten, EG | 1 |
| Hulshof, KF | 1 |
| Odink, J | 1 |
| Kok, FJ | 1 |
| Laurenzi, M | 1 |
| Menotti, A | 1 |
| Stamler, J | 3 |
| Stamler, R | 1 |
| Trevisan, M | 1 |
| Zanchetti, A | 1 |
| Collantes Estevez, E | 1 |
| Pineda Priego, M | 1 |
| Añon Barbudo, J | 1 |
| Sanchez Guijo, P | 1 |
| Panagiotopoulos, T | 1 |
| Ketelsen, UP | 1 |
| Schmidt, A | 1 |
| Heuck, CC | 1 |
| Darrelmann, O | 1 |
| Kreissig, I | 1 |
| Richard, G | 1 |
| Peschel, G | 1 |
| Scheffler, W | 1 |
| Bailey, A | 1 |
| Jensen, J | 1 |
| Blankenhorn, DH | 1 |
| Kornerup, V | 1 |
| Breckenridge, A | 1 |
| François, J | 1 |
| Tuyns, A | 1 |
| Hazzard, WR | 1 |
| Goldstein, JL | 1 |
| Schrott, MG | 1 |
| Motulsky, AG | 1 |
| Bierman, EL | 1 |
| Frank, O | 1 |
| Bertrand, E | 1 |
| Baudin, L | 1 |
| Chauvet, J | 1 |
| Assamoi, MO | 1 |
| Beda, B | 1 |
| Renambot, J | 1 |
| Thomas, JY | 1 |
| Le Bras, M | 1 |
| Garrick, R | 1 |
| Ewan, CE | 1 |
| Bauer, GE | 1 |
| Neale, FC | 1 |
| Blacket, RB | 2 |
| Leelarthaepin, B | 2 |
| Palmer, AJ | 2 |
| Woodhill, JM | 1 |
| Sirtori, C | 1 |
| Hurwitz, A | 1 |
| Sabih, K | 1 |
| Azarnoff, D | 1 |
| Barrow, MV | 1 |
| Ramsey, HW | 1 |
| Bortz, WM | 1 |
| Thiele, P | 2 |
| Schneider, V | 2 |
| Heidelmann, G | 2 |
| Mikus, F | 1 |
| Roux, H | 1 |
| Vovan, L | 1 |
| Dutertre, P | 1 |
| Serratrice, G | 1 |
| Recordier, AM | 1 |
| Klör, HU | 1 |
| Märtens, HR | 1 |
| van Eimeren, W | 1 |
| Härich, B | 1 |
| Ditschuneit, H | 1 |
| Förster, H | 1 |
| Heller, G | 1 |
| Haller, H | 1 |
| Leonhardt, W | 1 |
| Moser, W | 1 |
| Hanefeld, M | 1 |
| Cameron, JS | 1 |
| Himbert, J | 1 |
| Bensaid, J | 1 |
| Roussel, C | 1 |
| Ciświcka-Sznajderman, M | 1 |
| Ignatowska-Switalska, H | 1 |
| Sznajderman, M | 1 |
| Fessel, WJ | 1 |
| Crepaldi, G | 1 |
| Drake, JW | 1 |
| Bradford, RH | 1 |
| McDearmon, M | 1 |
| Furman, RH | 1 |
| Bossa, G | 1 |
| Giordano, M | 1 |
| D'Onofrio, F | 1 |
| Heyden, S | 3 |
| Gärtner, A | 1 |
| Tellkamp, F | 1 |
| Wollenweber, J | 1 |
| Doenecke, P | 1 |
| Greten, H | 1 |
| Hild, R | 1 |
| Nobbe, F | 1 |
| Schmidt, FH | 1 |
| Wagner, E | 1 |
| Knappe, J | 1 |
| Knappe, G | 1 |
| Strube, G | 1 |
| Dück, KD | 1 |
| Relke, W | 1 |
| Van Peenen, HJ | 1 |
| Bernheim, C | 1 |
| Haim, S | 1 |
| Gellei, B | 1 |
| Better, OS | 1 |
| Barrillon, A | 1 |
| Binet, JP | 1 |
| de Gennes, JL | 1 |
| Hazan, E | 1 |
| Lenègre, J | 1 |
| Hall, AP | 1 |
| Cannon, PJ | 1 |
| Stason, WB | 1 |
| Demartini, FE | 1 |
| Sommers, SC | 1 |
| Laragh, JH | 1 |
| Villiger, U | 2 |
| Heyden-Stucky, S | 1 |
| O'Brien, JR | 1 |
| Heywood, JB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Omentectomy for Treatment of Diabetes Mellitus Type 2[NCT00270439] | Phase 1 | 10 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| Phase 4 Study of the Effects of Pravastatin on Cholesterol Levels, Inflammation and Cognition in Schizophrenia[NCT01082588] | Phase 4 | 60 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| [NCT00005232] | 0 participants | Observational | 1988-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | g (Mean) |
|---|---|
| Ramelteon | 3934.86 |
| Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | HOMA score (Mean) |
|---|---|
| Ramelteon | 2.4 |
| Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | cm (Mean) |
|---|---|
| Ramelteon | 106.09 |
| Placebo (Sugar Pill) | 108.37 |
(NCT01082588)
Timeframe: Baseline, week 12
| Intervention | mg/L (Mean) |
|---|---|
| Pravastatin | 0.8063 |
| Placebo | -0.5136 |
(NCT01082588)
Timeframe: Baseline, week 12
| Intervention | mg/dl (Mean) |
|---|---|
| Pravastatin | -25.565 |
| Placebo | -2.913 |
"The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery measures cognitive functioning within 7 domains: speed of processing, attention/vigilance, working memory (non verbal and verbal), verbal learning, visual learning, reasoning and problem solving and social cognition.~The composite score is calculated by the MATRICS computer program, which equally weights each of the 7 domain scores. The range of composite scores is 20-80. Higher scores indicate higher levels or cognitive functioning, while lower scores indicate lower levels of cognitive functioning." (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | 4.0417 |
| Placebo | 4.125 |
This is a subscale of the Positive and Negative Syndrome Scale (PANSS). The range for this subscale is 15-105. All items are summed to calculate the total score. Better outcomes have lower numbers and worse outcomes have higher numbers. (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | -5.625 |
| Placebo | -3.76 |
This is a subscale of the Positive and Negative Syndrome Scale (PANSS). The range for this subscale is 7-49. All items are summed to calculate the total score. Better outcomes have lower numbers and worse outcomes have higher numbers. (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | -0.83 |
| Placebo | -0.28 |
This is a subscale of the Positive and Negative Syndrome Scale (PANSS). The range for this subscale is 7-49. All items are summed to calculate the total score. Better outcomes have lower numbers and worse outcomes have higher numbers. (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | -2.9583 |
| Placebo | -2.44 |
The Positive and Negative Syndrome Scale (PANSS) is a scale used to rate severity of schizophrenia. All items are summed to calculate the total score. The scale range is 30-210. Better outcomes have lower numbers and worse outcomes have higher numbers. (NCT01082588)
Timeframe: Baseline, week 12
| Intervention | Scores on a scale (Mean) |
|---|---|
| Pravastatin | -9.416 |
| Placebo | -6.48 |
5 reviews available for uric acid and Hypercholesterolemia
| Article | Year |
|---|---|
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.
Topics: Adipose Tissue; Arteriosclerosis; Coronary Disease; Fatty Acids, Nonesterified; Fibrinolysis; Flushi | 2005 |
[Current theories on the role of hyperuricemia as one of the risk factors in ischemic heart disease].
Topics: Carbohydrate Metabolism; Coronary Disease; Female; Gout; Humans; Hypercholesterolemia; Hypertension; | 1980 |
Precursors and prevention of coronary artery disease. An overview.
Topics: Aging; Coronary Disease; Diabetes Complications; Diet; Female; Humans; Hypercholesterolemia; Hyperli | 1972 |
Epidemiology of coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Cholesterol, Dietary; Coronary Disease; Diabetes Complications; Dieta | 1973 |
The pathogenesis of hypercholesterolemia.
Topics: Age Factors; Animals; Anxiety; Body Weight; Cholesterol; Diabetes Complications; Diet; Dietary Fats; | 1974 |
14 trials available for uric acid and Hypercholesterolemia
| Article | Year |
|---|---|
Associations between Dietary Glycemic Index and Glycemic Load Values and Cardiometabolic Risk Factors in Adults: Findings from the China Health and Nutrition Survey.
Topics: Adult; Age Factors; Aged; Blood Glucose; Cardiometabolic Risk Factors; China; Fasting; Female; Glyce | 2020 |
Daidzein supplementation decreases serum triglyceride and uric acid concentrations in hypercholesterolemic adults with the effect on triglycerides being greater in those with the GA compared with the GG genotype of ESR-β RsaI.
Topics: Adult; Aged; Asian People; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Energy | 2014 |
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; D | 2015 |
Comparison of the effects of diets high in animal or plant protein on metabolic and cardiovascular markers in type 2 diabetes: A randomized clinical trial.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Dairy Products; Diabe | 2017 |
The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Anti-Obesity Agents; Anticholesteremic Agents; | 2008 |
Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy.
Topics: Aged; Allantoin; Azetidines; Drug Administration Schedule; Drug Combinations; Ezetimibe; Female; Hum | 2012 |
Antioxidant and inflammatory response following high-fat meal consumption in overweight subjects.
Topics: Adult; Antioxidants; Body Mass Index; Diet, High-Fat; Female; Humans; Hypercholesterolemia; Hypertri | 2013 |
[Evaluation of lercanidipine in the general practice setting].
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Cholesterol; Diab | 2003 |
Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; C-Reactive Protein; Drug Sy | 2008 |
[Spa Treatment of increased uric acid and cholesterol levels].
Topics: Balneology; Diet Therapy; Female; Gout; Humans; Hypercholesterolemia; Male; Mineral Waters; Uric Aci | 1966 |
Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study.
Topics: Aged; Antioxidants; Ascorbic Acid; Coenzymes; Dietary Supplements; Double-Blind Method; Drug Interac | 2000 |
Clofibrate in type II hyperlipoproteinemia.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Female; Humans; Hypercholesterol | 1976 |
Clinical evaluation of MK-185: a new hypolipidemic drug.
Topics: Acetamides; Adult; Blood Protein Disorders; Blood Proteins; Cholesterol; Chromatography, Gas; Clinic | 1972 |
[Studies on the significance of carbohydrates in a fully synthetic fat-free diet].
Topics: Adult; Cholesterol; Creatinine; Dietary Carbohydrates; Female; Fructose; Humans; Hypercholesterolemi | 1973 |
125 other studies available for uric acid and Hypercholesterolemia
| Article | Year |
|---|---|
Polymorphisms of the genes
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Case-Control Studies; Genetic Predispositio | 2021 |
Polymorphisms of the genes
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Case-Control Studies; Genetic Predispositio | 2021 |
Polymorphisms of the genes
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Case-Control Studies; Genetic Predispositio | 2021 |
Polymorphisms of the genes
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Case-Control Studies; Genetic Predispositio | 2021 |
Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hy | 2023 |
Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis.
Topics: Atorvastatin; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cholesterol | 2023 |
Risk Factors for Hyperuricemia or Gout in Men and Women: The Circulatory Risk in Communities Study (CIRCS).
Topics: Diabetes Mellitus; Female; Gout; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; H | 2023 |
Serum uric acid and risk of incident hypercholesterolaemia and hypertriglyceridaemia in middle-aged and older Chinese: a 4-year prospective cohort study.
Topics: Aged; Biomarkers; China; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Hypercholestero | 2020 |
Clinical Significance of Serum Uric Acid Levels in Mexican Young Adults.
Topics: Adolescent; Adult; Cholesterol, LDL; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hu | 2018 |
Association of High Serum Uric Acid and Increased Arterial Stiffness is Dependent on Cardiovascular Risk Factors in Female Population.
Topics: Ankle Brachial Index; Biomarkers; Cardiovascular Diseases; China; Female; Humans; Hypercholesterolem | 2019 |
The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgens; Atorvastatin; C-Reactive Protein; Cardiovascular | 2019 |
Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients.
Topics: Adult; Allopurinol; Benzbromarone; Biomarkers; Cholesterol; Febuxostat; Female; Gout; Gout Suppressa | 2019 |
A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Dis | 2013 |
A new and fast methodology to assess oxidative damage in cardiovascular diseases risk development through eVol-MEPS-UHPLC analysis of four urinary biomarkers.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Biomarkers; Calibration; Case-Control Studies; Chromatography, H | 2013 |
Serum soluble toll-like receptor 2: a novel biomarker for systemic lupus erythematosus disease activity and lupus-related cardiovascular dysfunction.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Biomarkers; Case-Control Studies; Creatinine; | 2016 |
Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Blood Pressure; Body Mass Index; Cardiovascular Dise | 2015 |
Hyperuricemia is independently associated with left ventricular hypertrophy in post-menopausal women but not in pre-menopausal women in rural Northeast China.
Topics: Adult; Age Factors; Aged; Body Mass Index; China; Diabetes Mellitus; Dyslipidemias; Female; Humans; | 2015 |
Clinicopathologic features of IgA nephropathy patients with different levels of proteinuria.
Topics: Adult; Atrophy; Biopsy; Female; Fibrosis; Glomerular Filtration Rate; Glomerulonephritis, IGA; Glome | 2016 |
Gypenosides Inhibits Xanthine Oxidoreductase and Ameliorates Urate Excretion in Hyperuricemic Rats Induced by High Cholesterol and High Fat Food (Lipid Emulsion).
Topics: Animals; Cholesterol; Diet, High-Fat; Gynostemma; Hypercholesterolemia; Hyperuricemia; Kidney; Lipid | 2017 |
Edible mushroom Agaricus sylvaticus can prevent the onset of atheroma plaques in hipercholesterolemic rabbits.
Topics: Agaricus; Animals; Antioxidants; Aorta; Atherosclerosis; Cholesterol, Dietary; Hypercholesterolemia; | 2008 |
Abdominal fat accumulation with hyperuricemia and hypercholesterolemia quail model induced by high fat diet.
Topics: Abdominal Fat; Animals; Body Weight; Coturnix; Dietary Fats; Disease Models, Animal; Hypercholestero | 2009 |
Hyperuricaemia and accelerated reduction in renal function.
Topics: Adult; Aged; Chronic Disease; Cohort Studies; Creatinine; Disease Progression; Female; Follow-Up Stu | 2011 |
Effect of body mass index-z score on adverse levels of cardiovascular disease risk factors.
Topics: Adiponectin; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Child; Female; Humans; Hy | 2012 |
Oxidative stress and diabetes in pregnant rats.
Topics: Animals; Antioxidants; Congenital Abnormalities; Diabetes Mellitus, Experimental; Female; Gestationa | 2002 |
Significant correlation between insulin resistance and serum gamma-glutamyl transpeptidase (gamma-GTP) activity in non-drinkers.
Topics: Adult; Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Body Mass Index; Cholesterol; | 2002 |
Hyperuricemia; relationship to hypercholesteremia and acute myocardial infarction.
Topics: Anterior Wall Myocardial Infarction; Cardiovascular Diseases; Cholesterol; Humans; Hypercholesterole | 1959 |
Studies of nicotinic acid use in hypercholesteremia. Changes in hepatic function, carbohydrate tolerance, and uric acid metabolism.
Topics: Carbohydrates; Cholesterol; Hypercholesterolemia; Niacin; Nicotinic Acids; Uric Acid | 1961 |
STUDIES IN GLYCOSURIA AND DIABETES IN NON-WHITE POPULATIONS OF THE TRANSVAAL. II. INDIANS.
Topics: 17-Ketosteroids; Blood Proteins; Cerebrovascular Disorders; Diabetes Mellitus; Ethnology; Genetics, | 1963 |
[GOUT AND ARTERIOSCLEROSIS].
Topics: Arteriosclerosis; Biometry; Gout; Humans; Hypercholesterolemia; Statistics as Topic; Uric Acid | 1963 |
[CLINICAL CONTRIBUTION TO THE STUDY OF A NEW SYNTHETIC ANTICHOLESTEREMIC AGENT: BETA-BENZALBUTYRRAMIDE].
Topics: Amides; Anticholesteremic Agents; Arthritis; Arthritis, Rheumatoid; Asthma; Butyrates; Cholelithiasi | 1963 |
HYPERCHOLESTEROLEMIA INDUCED BY THIAZIDES: A PILOT STUDY.
Topics: Bendroflumethiazide; Biomedical Research; Blood Chemical Analysis; Cholesterol; Diet, Sodium-Restric | 1964 |
"ATROMID" IN ATHEROSCLEROSIS.
Topics: Androsterone; Angina Pectoris; Arteriosclerosis Obliterans; Atherosclerosis; Blood Chemical Analysis | 1964 |
BLOOD LIPID AND URIC ACID INTERRELATIONSHIPS.
Topics: Biomedical Research; Blood; Glycerides; Gout; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid M | 1964 |
CORRELATED VARIATIONS OF THE TOTAL LIPEMIA, CHOLESTEROLEMIA, BETA/ALPHA LIPOPROTEIN RATIO AND ORAL GLUCOSE TOLERANCE TEST.
Topics: Biomedical Research; Blood; Blood Glucose; Carbohydrate Metabolism; Cholesterol; Glucose Tolerance T | 1964 |
THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID.
Topics: Androsterone; Anticholesteremic Agents; Blood; Butyrates; Cholesterol; Dietary Fats; Drug Therapy; G | 1965 |
Association of hypercholesterolemia with hyperuricemia. A review of the literature.
Topics: Cholesterol; Humans; Hypercholesterolemia; Hyperuricemia; Uric Acid | 1962 |
Clustering of components of the metabolic syndrome and risk for development of type 2 diabetes in Japanese male office workers.
Topics: Adult; Analysis of Variance; Blood Glucose; Body Mass Index; Cholesterol, LDL; Cluster Analysis; Dia | 2004 |
Uric acid or 1-methyl uric acid in the urinary bladder increases serum glucose, insulin, true triglyceride, and total cholesterol levels in Wistar rats.
Topics: Administration, Intravesical; Animals; Blood Glucose; Cholesterol; Female; Hypercholesterolemia; Hyp | 2003 |
Disturbances in renal autoregulation and the susceptibility to hypertension-induced chronic kidney disease.
Topics: Aging; Animals; Diabetes Mellitus; Disease Models, Animal; Endothelium, Vascular; Fetal Growth Retar | 2004 |
Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
Topics: Allopurinol; Animals; Blood Pressure; Body Weight; Cholesterol; Creatinine; Enzyme Inhibitors; Heart | 2005 |
The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
Topics: Adult; Aged; Alcohol Drinking; China; Cross-Sectional Studies; Female; Gout; Humans; Hypercholestero | 2006 |
Relationships between toxemia of pregnancy and essential hypertension in a total community.
Topics: Adolescent; Adult; Blood Glucose; Child; Child, Preschool; Cholesterol; Eclampsia; Female; Glucose T | 1967 |
[Cardiological risk factors in Swiss men].
Topics: Adult; Albuminuria; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Coronary Disease; Glyco | 1967 |
Uric acid and diabetes: observations in a population study.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle A | 1982 |
Reversible cerebral ischemias: a comparative analysis of risk factors in TIAs and in RINDs.
Topics: Atrial Fibrillation; Brain Ischemia; Female; Hematocrit; Humans; Hypercholesterolemia; Hypertension; | 1984 |
[Angina pectoris in patients with arterial hypertension aged 40-59 years. I. Incidence and risk factors].
Topics: Adult; Angina Pectoris; Humans; Hypercholesterolemia; Hyperglycemia; Hypertension; Male; Middle Aged | 1984 |
Evaluation of the hypocholesterolemic effect of vegetable proteins.
Topics: Adult; Cholesterol; Cholesterol, HDL; Egg White; Fabaceae; Female; Humans; Hypercholesterolemia; Lip | 1983 |
Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents.
Topics: Adult; Antihypertensive Agents; Chemical Phenomena; Chemistry; Chlorthalidone; Diuretics; Humans; Hy | 1983 |
[The cardiovascular risk profile of the long-term diabetic].
Topics: Cardiovascular Diseases; Diabetes Complications; Humans; Hypercholesterolemia; Hypertension; Middle | 1982 |
[Long-term self-experimentation in the modification of blood cholesterol without the use of drugs].
Topics: Body Weight; Cholesterol; Cholesterol, HDL; Humans; Hypercholesterolemia; Lipoproteins, HDL; Middle | 1982 |
[Metabolic risk factors in the very old].
Topics: Aged; Aging; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Female; Humans; Hype | 1981 |
[The cardiovascular risk profile in patients with disorders of glucose tolerance (borderline diabetes) dependent on the heredity of the diabetes].
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; | 1981 |
[The cardiovascular risk profile in persons with normal glucose tolerance with reference to the familial occurrence of diabetes mellitus].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Diabetes Mellitus; Female; Glucose Tolerance Test; | 1981 |
Personal and familial factors in cholesterolemia: criteria for selection of a reference population.
Topics: Adult; Age Factors; Alcohol Drinking; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Contr | 1980 |
[Clinical risk factors in transient global amnesia and in transient ischaemic attacks (author's transl)].
Topics: Adult; Aged; Amnesia; Diabetes Complications; Female; Heart Failure; Humans; Hypercholesterolemia; H | 1980 |
[Study of associated risk factors and prevalence of heart diseases in patients with arterial hypertension].
Topics: Aged; Alcohol Drinking; Atrial Fibrillation; Coronary Disease; Data Interpretation, Statistical; Dia | 1995 |
[Arterial hypertension and diabetes in Ouagadougou (Burkina Faso)].
Topics: Adult; Aged; Burkina Faso; Diabetes Complications; Diabetic Angiopathies; Female; Humans; Hyperchole | 1996 |
[Influence of energy expenditure and other factors on the incidence of arterial hypertension in employees with some types of employment in Tychy].
Topics: Adolescent; Adult; Age Distribution; Aged; Air Pollution; Alcohol Drinking; Cholesterol; Energy Meta | 1996 |
[Relationship between metabolic changes and femur head necrosis].
Topics: Adult; Age Factors; Femur Head Necrosis; Humans; Hypercholesterolemia; Male; Risk Factors; Uric Acid | 1997 |
Treatment possibility of hypercholesterolaemia associated with hypertriglyceridaemia.
Topics: Apolipoprotein A-I; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; | 1997 |
Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism.
Topics: Adult; Arthritis, Gouty; Creatinine; Humans; Hypercholesterolemia; Hypothyroidism; Male; Renal Insuf | 1998 |
[Risk factors and etiology of retinal vein occlusion].
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Behcet Syndrome; Coronary Disease; Diabetes Complication | 1995 |
Health risk assessment for diabetes mellitus based on longitudinal analysis of MHTS database.
Topics: Adolescent; Adult; Age Factors; Aged; Alcohol Drinking; Analysis of Variance; Blood Glucose; Body Ma | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Homeos | 1998 |
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy.
Topics: Adolescent; Adult; Aged; Child; Female; Glomerulonephritis, IGA; Humans; Hypercholesterolemia; Hyper | 2000 |
Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels.
Topics: Adult; Aged; Aged, 80 and over; Cholesterol; Cholesterol, HDL; Coronary Disease; Fibrinolysis; Human | 2000 |
Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia?
Topics: Apolipoproteins B; Ascorbic Acid; Catalysis; Ceruloplasmin; Cholesterol; Cholesterol Esters; Cholest | 2001 |
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
Topics: Adult; Age Factors; Aged; Cholesterol; Coronary Disease; Female; Glucose Tolerance Test; Humans; Hyp | 1975 |
The effect of dietary changes on high density lipoprotein cholesterol. The Oslo Study.
Topics: Adult; Body Weight; Cholesterol; Cholesterol, Dietary; Humans; Hypercholesterolemia; Hyperlipidemias | 1979 |
[Important prognostic factors for the results of physiotherapeutic exercises in intermittent claudication (author's transl)].
Topics: Aged; Coronary Disease; Diabetes Complications; Exercise Therapy; Female; Humans; Hypercholesterolem | 1977 |
[Coronary risk factors and extent of angiographically proven coronary artery stenoses (author's transl)].
Topics: Angina Pectoris; Arteries; Arteriosclerosis; Constriction, Pathologic; Coronary Angiography; Coronar | 1979 |
[The cardiovascular risk profile of the borderline diabetic].
Topics: Adult; Aged; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Humans; Hypercholest | 1979 |
[Coronary risk factors].
Topics: Coronary Disease; Diabetes Complications; Diet; Female; Humans; Hypercholesterolemia; Hyperlipoprote | 1979 |
[Pathomorphology of the heart in angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Coronary Vessels; Death, Sudden; Diabetes Complications; Female; Human | 1978 |
[Conclusions from a clinical study of myocardial infarction in young men under 40 years of age].
Topics: Adult; Age Factors; Death, Sudden; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle Aged; M | 1977 |
[Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate].
Topics: Adult; Cholesterol; Coronary Disease; Humans; Hypercholesterolemia; Middle Aged; Theophylline; Uric | 1977 |
[Myocardial infarct in men under 40 years of age].
Topics: Adult; Age Factors; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarc | 1977 |
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases.
Topics: Adult; Cholesterol; Coronary Disease; Female; Heterozygote; Humans; Hypercholesterolemia; Hypertensi | 1976 |
[Serum cholesterol concentrations in various basic diseases. Studies in 2466 hospital patients].
Topics: Adult; Aged; Body Height; Body Weight; Cholesterol; Female; Hematologic Diseases; Hospital Records; | 1976 |
Coronary risk factors in New Zealand Maori and European adolescents: The Rotoua Lakes Study 2.
Topics: Adolescent; Body Height; Body Weight; Coronary Disease; Ethnicity; Female; Humans; Hypercholesterole | 1975 |
Effects of diuretics on lipid metabolism in patients with essential hypertension.
Topics: Adult; Blood Glucose; Cholesterol; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; | 1976 |
[Gout, hyperuricemia and femur head osteonecrosis (FHON)].
Topics: Adrenal Cortex Hormones; Adult; Female; Femur Head Necrosis; France; Gout; Humans; Hypercholesterole | 1975 |
[Latent diabetes mellitus as a risk factor in myocardial infarct].
Topics: Adult; Aged; Diabetes Complications; Humans; Hypercholesterolemia; Hypertension; Middle Aged; Myocar | 1975 |
Metabolic abnormalities in first-degree relatives of type 2 diabetics.
Topics: Adult; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Glucose; Glucose Tolerance | 1990 |
Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System).
Topics: Aged; Alcohol Drinking; Anthropometry; Antihypertensive Agents; Body Mass Index; Body Weight; Diet; | 1990 |
Multiple risk factors in hypertension: results from the Gubbio study.
Topics: Adult; Age Factors; Aged; Antiporters; Carrier Proteins; Erythrocytes; Female; Humans; Hypercholeste | 1990 |
Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse.
Topics: Adult; Alcohol Drinking; Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; H | 1990 |
Long-term effect of magnesium pyridoxal 5-phosphate glutamate in rabbits developing hypercholesterolemia.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Diet, Atherogenic; Fatty Acids, Nonesterified; Gluta | 1986 |
[Bilateral retinal vein occlusions and general risk factors].
Topics: Aged; Constriction, Pathologic; Diabetic Retinopathy; Female; Heart Failure; Humans; Hypercholestero | 1985 |
[8 years of SGPT screening at the District Institute for Blood Donation and Transfusion Services in Karl-Marx-Stadt].
Topics: Adult; Alanine Transaminase; Biopsy; Blood Donors; Clinical Enzyme Tests; Diabetes Mellitus; Fatty L | 1973 |
Biochemistry of well populations.
Topics: Adult; Biochemical Phenomena; Biochemistry; Blood Chemical Analysis; Blood Glucose; Blood Proteins; | 1974 |
Blood-uric-acid levels in familial hypercholesterolaemia.
Topics: Blood; Female; Gout; Hypercholesterolemia; Hyperlipidemias; Male; Statistics as Topic; Uric Acid | 1966 |
Hypertension and hyperuricaemia.
Topics: Adolescent; Adult; Aged; Blood; Cerebrovascular Disorders; Cobalt Isotopes; Coronary Disease; Female | 1966 |
[A systematic study of 46 cases of coronary arteriosclerosis].
Topics: 17-Ketosteroids; Adult; Alpha-Globulins; Beta-Globulins; Blood Pressure; Blood Protein Electrophores | 1966 |
Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipo | 1973 |
[Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia (author's transl)].
Topics: Carbohydrate Metabolism; Cholesterol; Coronary Disease; Diabetes Complications; Female; Gout; Humans | 1974 |
[Coronaropathies in the black African. Clinical, etiological and current epidemiological aspects (apropos of 45 cases)].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Black People; Coronary Disease; Cote d'Ivoire; Diabetes C | 1974 |
Serum uric acid in normal and hypertensive Australian subjects.
Topics: Adolescent; Adult; Age Factors; Australia; Child; Colorimetry; Debrisoquin; Female; Guanethidine; Hu | 1972 |
Coronary heart disease in young men: a study of seventy patients with a critical review of etiological factors.
Topics: Adult; Australia; Body Height; Body Weight; Cholesterol, Dietary; Coronary Disease; Diabetes Complic | 1973 |
[Reciprocal relationship between purine metabolism disorders and arteriosclerotic angioorganopathies].
Topics: Age Factors; Arm; Arterial Occlusive Diseases; Arteriosclerosis; Cholesterol; Diabetes Complications | 1972 |
[Hyperuricemia and myocardial infarct].
Topics: Arteriosclerosis; Coronary Disease; Diabetes Complications; Female; Gout; Humans; Hypercholesterolem | 1972 |
[Lipid disorders in gout and in hyperuricemia with myalgia].
Topics: Adult; Aged; Cholesterol; Female; Gout; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipop | 1972 |
[Hyperlipidemia and other risk factors in coronary sclerosis].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Complications; Glucose Tolerance Test; Humans; | 1972 |
[Relation of blood pressure to the body weight index and to metabolic parameters].
Topics: Adolescent; Adult; Age Factors; Aged; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diet, | 1973 |
Hyperlipidaemia in a group of coronary subjects in Sydney.
Topics: Adult; Age Factors; Body Height; Body Weight; Cholesterol; Coronary Disease; Diet; Humans; Hyperchol | 1973 |
Uric acid and the kidney.
Topics: Aged; Allopurinol; Animals; Diabetes Mellitus; Gout; Humans; Hydrogen-Ion Concentration; Hypercholes | 1973 |
[First results of the application to cardiovascular diseases of a new preventive medicine concept using automatic treatment of the information by computer].
Topics: Adult; Aged; Angina Pectoris; Body Weight; Cardiovascular Diseases; Computers; Diabetes Mellitus; El | 1971 |
Long-term treatment of hyperlipidemic patients with clofibrate.
Topics: Adult; Aged; Body Weight; Cholesterol; Clofibrate; Female; Glucose; Glucose Tolerance Test; Humans; | 1971 |
Coronary heart disease: risk factors as guides to preventive action.
Topics: Adult; Coronary Disease; Dietary Fats; Female; Humans; Hypercholesterolemia; Hyperglycemia; Hyperten | 1972 |
Uric acid level, coronary heart disease and serum lipids.
Topics: Adult; Cholesterol; Coronary Disease; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Trigl | 1972 |
Hyperuricemia in health and disease.
Topics: Arteriosclerosis; Arthritis; Blood Group Antigens; Carbohydrate Metabolism; Diabetes Complications; | 1972 |
[Relations between diet and atherosclerosis].
Topics: Adult; Age Factors; Arteriosclerosis; Coronary Disease; Diet; Dietary Carbohydrates; Dietary Fats; D | 1971 |
The effect of [4,4'-(isopropylidenethio)bis(2,6-di-t-butylphenol)] (DH-581) on serum lipids and lipoproteins in human subjects.
Topics: Anticholesteremic Agents; Chemical Phenomena; Chemistry; Cholesterol; Diabetes Complications; Dietar | 1969 |
[Clinical and metabolic problems in the degenerative joint disease of the diabetic].
Topics: Adult; Age Factors; Aged; Arthritis, Rheumatoid; Arthropathy, Neurogenic; Calcaneus; Calcinosis; Dia | 1970 |
[Dietary management of hazard factors in cardiovascular diseases].
Topics: Aged; Cardiovascular Diseases; Diabetes Complications; Diet Therapy; Humans; Hypercholesterolemia; H | 1970 |
[Current problems of gout].
Topics: Blood Glucose; Cholesterol; Coronary Disease; Diabetes Complications; Female; Gout; Humans; Hypercho | 1970 |
[Incidence of hyperlipemia, hyperuricemia, diabetes mellitus, hypertension and overweight in arterial obliterating disease].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Blood Glucose; Body Weight; Cholesterol; Diabetic Angiopat | 1971 |
[Ischemic heart disease and so-called risk factors--results of an epidemiological study in Erfurt].
Topics: Angina Pectoris; Blood Glucose; Cardiovascular Diseases; Computers; Coronary Disease; Fatty Acids, E | 1971 |
The causes of nonazotemic hyperuricemia.
Topics: Adult; Age Factors; Animals; Arteriosclerosis; Blood Urea Nitrogen; Computers; Coronary Disease; Dia | 1971 |
[The BBC study. Applied epidemiology of ischemic heart diseases].
Topics: Adult; Body Weight; Caffeine; Cholesterol; Coronary Disease; Epidemiologic Methods; Hematocrit; Huma | 1967 |
[Gout and diabetes. II. Diabetes and its relation to saluretic-induced diabetes and hyperuricemia].
Topics: Aged; Carbohydrate Metabolism; Chlorothiazide; Cholesterol; Diabetes Mellitus; Female; Gout; Humans; | 1968 |
Cutaneous manifestation in combined lipids and urate metabolic disorders.
Topics: Diet Therapy; Female; Follow-Up Studies; Granuloma; Humans; Hypercholesterolemia; Hyperlipidemias; M | 1969 |
[Basic treatment of coronary atherosclerosis].
Topics: Activities of Daily Living; Angina Pectoris; Anticoagulants; Cholesterol; Cholestyramine Resin; Coro | 1969 |
Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension.
Topics: Blood; Coronary Disease; Epidemiologic Methods; Gout; Humans; Hypercholesterolemia; Hypertension; Ur | 1965 |
Hyperuricemia in primary and renal hypertension.
Topics: Adolescent; Adult; Aged; Blood Urea Nitrogen; Female; Glomerular Filtration Rate; Humans; Hyperchole | 1966 |
[The infarct profile. Differences between infarct patients and control subjects in Eastern Switzerland].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Arthritis; Body Height; Body Weight; Cholesterol; Diabete | 1966 |
A comparison of platelet stickiness tests during an atromid-S trial.
Topics: Adenine Nucleotides; Adult; Androsterone; Anticholesteremic Agents; Blood Coagulation Tests; Blood P | 1966 |
[New results in epidemiological research in ischemic heart disease. I. Retrospective epidemiological observation: alcohol consumption of infarct patients. II. Prospective epidemiological observation: the EKG before and after infarct--the EKG in population
Topics: Adult; Alcoholism; Arteriosclerosis; Cholesterol; Diet, Atherogenic; Electrocardiography; Epidemiolo | 1966 |